- Home
- ICCM vs MDCX Comparison
ICCM vs MDCX Comparison
Compare ICCM & MDCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | ICCM | MDCX |
|---|---|---|
| Founded | 2006 | 2008 |
| Country | Israel | United States |
| Employees | N/A | 16 |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.4M | 17.1M |
| IPO Year | 2013 | N/A |
Fundamental Metrics
Financial Performance| Metric | ICCM | MDCX |
|---|---|---|
| Price | $3.25 | $0.32 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $2.50 | ★ $14.50 |
| AVG Volume (30 Days) | 75.6K | ★ 1.6M |
| Earning Date | 05-27-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $139.51 | N/A |
| Revenue Next Year | $75.66 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.13 | $0.25 |
| 52 Week High | $9.54 | $3.05 |
Technical Indicators
Market Signals| Indicator | ICCM | MDCX |
|---|---|---|
| Relative Strength Index (RSI) | 50.21 | 45.75 |
| Support Level | $0.61 | $0.26 |
| Resistance Level | $5.69 | $0.41 |
| Average True Range (ATR) | 0.30 | 0.03 |
| MACD | 0.02 | -0.00 |
| Stochastic Oscillator | 70.46 | 39.15 |
Price Performance
Historical Comparison ICCM
MDCX
About ICCM IceCure Medical Ltd.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.
About MDCX Medicus Pharma Ltd.
Medicus Pharma Ltd is a clinical-stage, life sciences, biotech company focused on investing in and accelerating clinical development programs of novel and potentially disruptive therapeutic assets. The company has one operating segment.